Clinuvel Pharmaceuticals Ltd
ASX:CUV
Income Statement
Earnings Waterfall
Clinuvel Pharmaceuticals Ltd
Revenue
|
87.3m
AUD
|
Cost of Revenue
|
8.1m
AUD
|
Gross Profit
|
95.4m
AUD
|
Operating Expenses
|
-44.5m
AUD
|
Operating Income
|
50.8m
AUD
|
Other Expenses
|
-20.7m
AUD
|
Net Income
|
30.2m
AUD
|
Income Statement
Clinuvel Pharmaceuticals Ltd
Dec-2003 | Jun-2004 | Dec-2004 | Jun-2005 | Dec-2005 | Jun-2006 | Dec-2006 | Jun-2007 | Dec-2007 | Jun-2008 | Dec-2008 | Jun-2009 | Dec-2009 | Jun-2010 | Dec-2010 | Jun-2011 | Dec-2011 | Jun-2012 | Dec-2012 | Jun-2013 | Dec-2013 | Jun-2014 | Dec-2014 | Jun-2015 | Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
+64%
|
0
+28%
|
1
+30%
|
1
+48%
|
1
+35%
|
2
+36%
|
3
+56%
|
4
+45%
|
4
+16%
|
5
+15%
|
3
-41%
|
3
-4%
|
2
-34%
|
1
-51%
|
2
+149%
|
1
-60%
|
1
+44%
|
2
+66%
|
3
+34%
|
3
-7%
|
3
+11%
|
3
+8%
|
4
+14%
|
4
+12%
|
7
+71%
|
12
+75%
|
17
+38%
|
17
+1%
|
26
+50%
|
28
+10%
|
32
+12%
|
33
+3%
|
33
+1%
|
39
+17%
|
48
+25%
|
57
+18%
|
66
+16%
|
72
+9%
|
82
+14%
|
87
+6%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
2
|
2
|
(1)
|
1
|
8
|
8
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
32
N/A
|
38
+18%
|
50
+32%
|
59
+17%
|
65
+10%
|
73
+13%
|
90
+22%
|
95
+6%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(6)
|
(8)
|
(9)
|
(13)
|
(12)
|
(12)
|
(12)
|
(12)
|
(14)
|
(19)
|
(21)
|
(19)
|
(16)
|
(14)
|
(14)
|
(14)
|
(14)
|
(11)
|
(10)
|
(10)
|
(8)
|
(8)
|
(13)
|
(14)
|
(11)
|
(10)
|
(10)
|
(10)
|
(11)
|
(13)
|
(13)
|
(14)
|
(18)
|
(18)
|
(18)
|
(21)
|
(26)
|
(28)
|
(30)
|
(41)
|
(45)
|
|
Selling, General & Administrative |
0
|
0
|
(1)
|
(4)
|
(6)
|
(5)
|
(4)
|
0
|
(2)
|
(12)
|
(13)
|
(10)
|
(10)
|
(7)
|
(7)
|
(6)
|
(7)
|
(6)
|
(5)
|
(6)
|
(6)
|
(6)
|
(10)
|
(12)
|
(8)
|
(8)
|
(7)
|
(7)
|
(8)
|
(9)
|
(8)
|
(9)
|
(11)
|
(18)
|
(19)
|
(19)
|
(27)
|
(26)
|
(28)
|
(39)
|
(42)
|
|
Research & Development |
(2)
|
(5)
|
(6)
|
(5)
|
(5)
|
(4)
|
(4)
|
(3)
|
(5)
|
(6)
|
(8)
|
(8)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(5)
|
(5)
|
(4)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(5)
|
(5)
|
(6)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
Depreciation & Amortization |
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
Other Operating Expenses |
(3)
|
(2)
|
(1)
|
(2)
|
0
|
(2)
|
(2)
|
(8)
|
(5)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(1)
|
0
|
3
|
0
|
3
|
0
|
0
|
0
|
0
|
|
Operating Income |
(6)
N/A
|
(8)
-28%
|
(9)
-18%
|
(12)
-34%
|
(12)
+4%
|
(11)
+7%
|
(10)
+7%
|
(9)
+8%
|
(10)
-10%
|
(15)
-49%
|
(16)
-4%
|
(16)
-1%
|
(13)
+16%
|
(12)
+7%
|
(13)
-2%
|
(11)
+10%
|
(13)
-18%
|
(10)
+28%
|
(8)
+19%
|
(7)
+12%
|
(6)
+18%
|
(6)
+2%
|
(10)
-77%
|
(10)
-8%
|
(6)
+39%
|
(3)
+48%
|
3
N/A
|
7
+167%
|
6
-19%
|
12
+118%
|
15
+22%
|
17
+13%
|
15
-14%
|
14
-6%
|
20
+46%
|
30
+45%
|
33
+12%
|
37
+11%
|
43
+16%
|
49
+15%
|
51
+3%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
(2)
|
0
|
3
|
1
|
1
|
(0)
|
1
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
1
|
(0)
|
(1)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(3)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(6)
N/A
|
(8)
-28%
|
(9)
-18%
|
(12)
-34%
|
(12)
+4%
|
(11)
+7%
|
(10)
+7%
|
(9)
+8%
|
(12)
-28%
|
(15)
-25%
|
(17)
-17%
|
(15)
+11%
|
(11)
+30%
|
(12)
-7%
|
(12)
-4%
|
(11)
+5%
|
(13)
-11%
|
(10)
+23%
|
(8)
+19%
|
(7)
+14%
|
(6)
+16%
|
(6)
+3%
|
(10)
-75%
|
(10)
-8%
|
(6)
+39%
|
(3)
+50%
|
3
N/A
|
7
+171%
|
6
-16%
|
13
+116%
|
16
+21%
|
18
+16%
|
15
-19%
|
12
-21%
|
17
+45%
|
26
+54%
|
29
+11%
|
34
+20%
|
40
+17%
|
46
+13%
|
46
+0%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
4
|
(1)
|
(5)
|
(13)
|
(14)
|
(15)
|
(16)
|
|
Income from Continuing Operations |
(6)
|
(8)
|
(9)
|
(12)
|
(12)
|
(11)
|
(10)
|
(9)
|
(12)
|
(15)
|
(17)
|
(15)
|
(11)
|
(12)
|
(12)
|
(11)
|
(13)
|
(10)
|
(8)
|
(7)
|
(6)
|
(6)
|
(10)
|
(10)
|
(6)
|
(3)
|
3
|
7
|
6
|
13
|
16
|
18
|
15
|
15
|
21
|
25
|
24
|
21
|
26
|
31
|
30
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
(6)
N/A
|
(8)
-28%
|
(9)
-18%
|
(12)
-34%
|
(12)
+4%
|
(11)
+7%
|
(10)
+7%
|
(9)
+8%
|
(12)
-28%
|
(15)
-25%
|
(17)
-17%
|
(15)
+11%
|
(11)
+30%
|
(12)
-7%
|
(12)
-4%
|
(11)
+5%
|
(13)
-11%
|
(10)
+23%
|
(8)
+19%
|
(7)
+14%
|
(6)
+16%
|
(6)
+3%
|
(10)
-75%
|
(10)
-8%
|
(6)
+39%
|
(3)
+51%
|
3
N/A
|
7
+168%
|
6
-15%
|
13
+118%
|
16
+20%
|
18
+14%
|
15
-19%
|
15
+3%
|
21
+39%
|
25
+18%
|
24
-2%
|
21
-13%
|
26
+26%
|
31
+16%
|
30
-1%
|
|
EPS (Diluted) |
-0.53
N/A
|
-0.66
-25%
|
-0.65
+2%
|
-0.94
-45%
|
-0.65
+31%
|
-0.67
-3%
|
-0.45
+33%
|
-0.27
+40%
|
-0.37
-37%
|
-0.49
-32%
|
-0.58
-18%
|
-0.51
+12%
|
-0.36
+29%
|
-0.38
-6%
|
-0.39
-3%
|
-0.38
+3%
|
-0.42
-11%
|
-0.32
+24%
|
-0.24
+25%
|
-0.19
+21%
|
-0.15
+21%
|
-0.14
+7%
|
-0.23
-64%
|
-0.24
-4%
|
-0.14
+42%
|
-0.07
+50%
|
0.05
N/A
|
0.14
+180%
|
0.12
-14%
|
0.27
+125%
|
0.33
+22%
|
0.37
+12%
|
0.29
-22%
|
0.3
+3%
|
0.43
+43%
|
0.48
+12%
|
0.48
N/A
|
0.4
-17%
|
0.5
+25%
|
0.59
+18%
|
0.58
-2%
|